nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—Anaphylactoid reaction—Irinotecan—colon cancer	0.0202	0.0202	CcSEcCtD
Orciprenaline—Hypokalaemia—Irinotecan—colon cancer	0.0178	0.0178	CcSEcCtD
Orciprenaline—Cramp muscle—Irinotecan—colon cancer	0.0176	0.0176	CcSEcCtD
Orciprenaline—Sweating increased—Irinotecan—colon cancer	0.0165	0.0165	CcSEcCtD
Orciprenaline—Sweating—Vincristine—colon cancer	0.0149	0.0149	CcSEcCtD
Orciprenaline—Sweating—Irinotecan—colon cancer	0.0145	0.0145	CcSEcCtD
Orciprenaline—Chills—Irinotecan—colon cancer	0.0122	0.0122	CcSEcCtD
Orciprenaline—Arrhythmia—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Orciprenaline—Hypokalaemia—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Orciprenaline—Arrhythmia—Fluorouracil—colon cancer	0.0116	0.0116	CcSEcCtD
Orciprenaline—Muscle spasms—Irinotecan—colon cancer	0.0113	0.0113	CcSEcCtD
Orciprenaline—Asthma—Capecitabine—colon cancer	0.0113	0.0113	CcSEcCtD
Orciprenaline—Influenza—Capecitabine—colon cancer	0.0113	0.0113	CcSEcCtD
Orciprenaline—Bronchospasm—Capecitabine—colon cancer	0.0111	0.0111	CcSEcCtD
Orciprenaline—Sweating increased—Capecitabine—colon cancer	0.011	0.011	CcSEcCtD
Orciprenaline—Abdominal discomfort—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Orciprenaline—Vision blurred—Fluorouracil—colon cancer	0.0106	0.0106	CcSEcCtD
Orciprenaline—Syncope—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Orciprenaline—Hypertension—Vincristine—colon cancer	0.0105	0.0105	CcSEcCtD
Orciprenaline—Loss of consciousness—Irinotecan—colon cancer	0.0104	0.0104	CcSEcCtD
Orciprenaline—Myalgia—Vincristine—colon cancer	0.0103	0.0103	CcSEcCtD
Orciprenaline—Cough—Irinotecan—colon cancer	0.0103	0.0103	CcSEcCtD
Orciprenaline—Hypertension—Irinotecan—colon cancer	0.0102	0.0102	CcSEcCtD
Orciprenaline—Anaphylactoid reaction—Methotrexate—colon cancer	0.0101	0.0101	CcSEcCtD
Orciprenaline—Oedema—Vincristine—colon cancer	0.00988	0.00988	CcSEcCtD
Orciprenaline—Anaphylactic shock—Vincristine—colon cancer	0.00988	0.00988	CcSEcCtD
Orciprenaline—Anaphylactic shock—Irinotecan—colon cancer	0.00962	0.00962	CcSEcCtD
Orciprenaline—Oedema—Irinotecan—colon cancer	0.00962	0.00962	CcSEcCtD
Orciprenaline—Chest pain—Fluorouracil—colon cancer	0.00962	0.00962	CcSEcCtD
Orciprenaline—Myalgia—Fluorouracil—colon cancer	0.00962	0.00962	CcSEcCtD
Orciprenaline—Hyperhidrosis—Vincristine—colon cancer	0.00955	0.00955	CcSEcCtD
Orciprenaline—Shock—Irinotecan—colon cancer	0.00947	0.00947	CcSEcCtD
Orciprenaline—Hyperhidrosis—Irinotecan—colon cancer	0.0093	0.0093	CcSEcCtD
Orciprenaline—Oedema—Fluorouracil—colon cancer	0.00922	0.00922	CcSEcCtD
Orciprenaline—Anaphylactic shock—Fluorouracil—colon cancer	0.00922	0.00922	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Vincristine—colon cancer	0.009	0.009	CcSEcCtD
Orciprenaline—Tachycardia—Fluorouracil—colon cancer	0.009	0.009	CcSEcCtD
Orciprenaline—Insomnia—Vincristine—colon cancer	0.00894	0.00894	CcSEcCtD
Orciprenaline—Insomnia—Irinotecan—colon cancer	0.0087	0.0087	CcSEcCtD
Orciprenaline—Somnolence—Irinotecan—colon cancer	0.00856	0.00856	CcSEcCtD
Orciprenaline—Fatigue—Vincristine—colon cancer	0.00852	0.00852	CcSEcCtD
Orciprenaline—Pain—Vincristine—colon cancer	0.00845	0.00845	CcSEcCtD
Orciprenaline—Asthma—Methotrexate—colon cancer	0.00843	0.00843	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0084	0.0084	CcSEcCtD
Orciprenaline—Insomnia—Fluorouracil—colon cancer	0.00834	0.00834	CcSEcCtD
Orciprenaline—Fatigue—Irinotecan—colon cancer	0.0083	0.0083	CcSEcCtD
Orciprenaline—Pain—Irinotecan—colon cancer	0.00823	0.00823	CcSEcCtD
Orciprenaline—Somnolence—Fluorouracil—colon cancer	0.00819	0.00819	CcSEcCtD
Orciprenaline—Chills—Capecitabine—colon cancer	0.00813	0.00813	CcSEcCtD
Orciprenaline—Arrhythmia—Capecitabine—colon cancer	0.0081	0.0081	CcSEcCtD
Orciprenaline—Abdominal discomfort—Methotrexate—colon cancer	0.00808	0.00808	CcSEcCtD
Orciprenaline—Pain—Fluorouracil—colon cancer	0.00788	0.00788	CcSEcCtD
Orciprenaline—Body temperature increased—Vincristine—colon cancer	0.00781	0.00781	CcSEcCtD
Orciprenaline—Dysgeusia—Capecitabine—colon cancer	0.00773	0.00773	CcSEcCtD
Orciprenaline—Body temperature increased—Irinotecan—colon cancer	0.00761	0.00761	CcSEcCtD
Orciprenaline—Muscle spasms—Capecitabine—colon cancer	0.00759	0.00759	CcSEcCtD
Orciprenaline—Drowsiness—Methotrexate—colon cancer	0.00752	0.00752	CcSEcCtD
Orciprenaline—Vision blurred—Capecitabine—colon cancer	0.00744	0.00744	CcSEcCtD
Orciprenaline—Tremor—Capecitabine—colon cancer	0.00739	0.00739	CcSEcCtD
Orciprenaline—Urticaria—Fluorouracil—colon cancer	0.00732	0.00732	CcSEcCtD
Orciprenaline—Body temperature increased—Fluorouracil—colon cancer	0.00729	0.00729	CcSEcCtD
Orciprenaline—Hypersensitivity—Vincristine—colon cancer	0.00728	0.00728	CcSEcCtD
Orciprenaline—Sweating—Methotrexate—colon cancer	0.00721	0.00721	CcSEcCtD
Orciprenaline—Hypersensitivity—Irinotecan—colon cancer	0.00709	0.00709	CcSEcCtD
Orciprenaline—Asthenia—Vincristine—colon cancer	0.00709	0.00709	CcSEcCtD
Orciprenaline—Syncope—Capecitabine—colon cancer	0.00708	0.00708	CcSEcCtD
Orciprenaline—Palpitations—Capecitabine—colon cancer	0.00697	0.00697	CcSEcCtD
Orciprenaline—Loss of consciousness—Capecitabine—colon cancer	0.00694	0.00694	CcSEcCtD
Orciprenaline—Asthenia—Irinotecan—colon cancer	0.00691	0.00691	CcSEcCtD
Orciprenaline—Cough—Capecitabine—colon cancer	0.00689	0.00689	CcSEcCtD
Orciprenaline—Hypertension—Capecitabine—colon cancer	0.00681	0.00681	CcSEcCtD
Orciprenaline—Hypersensitivity—Fluorouracil—colon cancer	0.00679	0.00679	CcSEcCtD
Orciprenaline—Diarrhoea—Vincristine—colon cancer	0.00676	0.00676	CcSEcCtD
Orciprenaline—Chest pain—Capecitabine—colon cancer	0.00672	0.00672	CcSEcCtD
Orciprenaline—Myalgia—Capecitabine—colon cancer	0.00672	0.00672	CcSEcCtD
Orciprenaline—Diarrhoea—Irinotecan—colon cancer	0.00658	0.00658	CcSEcCtD
Orciprenaline—Dry mouth—Capecitabine—colon cancer	0.00657	0.00657	CcSEcCtD
Orciprenaline—Dizziness—Vincristine—colon cancer	0.00653	0.00653	CcSEcCtD
Orciprenaline—Pruritus—Fluorouracil—colon cancer	0.00652	0.00652	CcSEcCtD
Orciprenaline—Oedema—Capecitabine—colon cancer	0.00644	0.00644	CcSEcCtD
Orciprenaline—Dizziness—Irinotecan—colon cancer	0.00636	0.00636	CcSEcCtD
Orciprenaline—Shock—Capecitabine—colon cancer	0.00634	0.00634	CcSEcCtD
Orciprenaline—Diarrhoea—Fluorouracil—colon cancer	0.00631	0.00631	CcSEcCtD
Orciprenaline—Tachycardia—Capecitabine—colon cancer	0.00629	0.00629	CcSEcCtD
Orciprenaline—Vomiting—Vincristine—colon cancer	0.00628	0.00628	CcSEcCtD
Orciprenaline—Hyperhidrosis—Capecitabine—colon cancer	0.00623	0.00623	CcSEcCtD
Orciprenaline—Headache—Vincristine—colon cancer	0.00619	0.00619	CcSEcCtD
Orciprenaline—Vomiting—Irinotecan—colon cancer	0.00612	0.00612	CcSEcCtD
Orciprenaline—Dizziness—Fluorouracil—colon cancer	0.0061	0.0061	CcSEcCtD
Orciprenaline—Chills—Methotrexate—colon cancer	0.00606	0.00606	CcSEcCtD
Orciprenaline—Headache—Irinotecan—colon cancer	0.00603	0.00603	CcSEcCtD
Orciprenaline—Nausea—Vincristine—colon cancer	0.00587	0.00587	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00587	0.00587	CcSEcCtD
Orciprenaline—Vomiting—Fluorouracil—colon cancer	0.00586	0.00586	CcSEcCtD
Orciprenaline—Insomnia—Capecitabine—colon cancer	0.00583	0.00583	CcSEcCtD
Orciprenaline—Headache—Fluorouracil—colon cancer	0.00577	0.00577	CcSEcCtD
Orciprenaline—Dysgeusia—Methotrexate—colon cancer	0.00575	0.00575	CcSEcCtD
Orciprenaline—Nausea—Irinotecan—colon cancer	0.00572	0.00572	CcSEcCtD
Orciprenaline—Fatigue—Capecitabine—colon cancer	0.00555	0.00555	CcSEcCtD
Orciprenaline—Vision blurred—Methotrexate—colon cancer	0.00554	0.00554	CcSEcCtD
Orciprenaline—Pain—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Orciprenaline—Nausea—Fluorouracil—colon cancer	0.00548	0.00548	CcSEcCtD
Orciprenaline—Cough—Methotrexate—colon cancer	0.00513	0.00513	CcSEcCtD
Orciprenaline—Urticaria—Capecitabine—colon cancer	0.00512	0.00512	CcSEcCtD
Orciprenaline—Body temperature increased—Capecitabine—colon cancer	0.00509	0.00509	CcSEcCtD
Orciprenaline—Chest pain—Methotrexate—colon cancer	0.005	0.005	CcSEcCtD
Orciprenaline—Myalgia—Methotrexate—colon cancer	0.005	0.005	CcSEcCtD
Orciprenaline—Anaphylactic shock—Methotrexate—colon cancer	0.0048	0.0048	CcSEcCtD
Orciprenaline—Hypersensitivity—Capecitabine—colon cancer	0.00475	0.00475	CcSEcCtD
Orciprenaline—Hyperhidrosis—Methotrexate—colon cancer	0.00464	0.00464	CcSEcCtD
Orciprenaline—Asthenia—Capecitabine—colon cancer	0.00462	0.00462	CcSEcCtD
Orciprenaline—Pruritus—Capecitabine—colon cancer	0.00456	0.00456	CcSEcCtD
Orciprenaline—Diarrhoea—Capecitabine—colon cancer	0.00441	0.00441	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00437	0.00437	CcSEcCtD
Orciprenaline—Insomnia—Methotrexate—colon cancer	0.00434	0.00434	CcSEcCtD
Orciprenaline—Somnolence—Methotrexate—colon cancer	0.00426	0.00426	CcSEcCtD
Orciprenaline—Dizziness—Capecitabine—colon cancer	0.00426	0.00426	CcSEcCtD
Orciprenaline—Fatigue—Methotrexate—colon cancer	0.00413	0.00413	CcSEcCtD
Orciprenaline—Pain—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Orciprenaline—Vomiting—Capecitabine—colon cancer	0.0041	0.0041	CcSEcCtD
Orciprenaline—Headache—Capecitabine—colon cancer	0.00404	0.00404	CcSEcCtD
Orciprenaline—Nausea—Capecitabine—colon cancer	0.00383	0.00383	CcSEcCtD
Orciprenaline—Urticaria—Methotrexate—colon cancer	0.00381	0.00381	CcSEcCtD
Orciprenaline—Body temperature increased—Methotrexate—colon cancer	0.00379	0.00379	CcSEcCtD
Orciprenaline—Hypersensitivity—Methotrexate—colon cancer	0.00353	0.00353	CcSEcCtD
Orciprenaline—Asthenia—Methotrexate—colon cancer	0.00344	0.00344	CcSEcCtD
Orciprenaline—Pruritus—Methotrexate—colon cancer	0.00339	0.00339	CcSEcCtD
Orciprenaline—Diarrhoea—Methotrexate—colon cancer	0.00328	0.00328	CcSEcCtD
Orciprenaline—Dizziness—Methotrexate—colon cancer	0.00317	0.00317	CcSEcCtD
Orciprenaline—Vomiting—Methotrexate—colon cancer	0.00305	0.00305	CcSEcCtD
Orciprenaline—Headache—Methotrexate—colon cancer	0.003	0.003	CcSEcCtD
Orciprenaline—Nausea—Methotrexate—colon cancer	0.00285	0.00285	CcSEcCtD
